NASDAQ : SENS
Senseonics Holdings, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 9.47 USD (Oct 30, 2026, 10:10 AM EDT) · Market cap 500.72M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 474.81M |
| Enterprise Value | 394.97M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 52.87M |
| Shares Outstanding | 52.87M |
| Shares Change (YoY) | +37.63% |
| Shares Change (QoQ) | +26.23% |
| Owned by Insiders (%) | 8.73% |
| Owned by Institutions (%) | 29.36% |
| Float | 43.67M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.75 |
| Forward PS | 6.01 |
| PB Ratio | 5.57 |
| P/TBV Ratio | 5.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 8.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 6.74 |
| Quick Ratio | 6.22 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.96 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -118.24% |
| Return on Assets (ROA) | -41.41% |
| Return on Invested Capital (ROIC) | -46.85% |
| Return on Capital Employed (ROCE) | -71.22% |
| Weighted Average Cost of Capital (WACC) | 9.53% |
| Revenue Per Employee | $373,423 |
| Profits Per Employee | -$841,469 |
| Employee Count | 130 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 3.33 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +26.95% |
| 50-Day Moving Average | 9.17 |
| 200-Day Moving Average | 7.21 |
| Relative Strength Index (RSI) | 51.71 |
| Average Volume (20 Days) | 599,377 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.87M |
| Short Previous Month | 5.37M |
| Short % of Shares Out | 9.21% |
| Short % of Float | 11.15% |
| Short Ratio (days to cover) | 6.68 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 48.55M |
| Gross Profit | 26.64M |
| Operating Income | -108.36M |
| Pretax Income | -109.39M |
| Net Income | -109.39M |
| EBITDA | -106.51M |
| EBIT | -108.36M |
| Loss Per Share | -$2.26 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 142.66M |
| Total Debt | 62.82M |
| Net Cash | 79.84M |
| Net Cash Per Share | $1.51 |
| Equity (Book Value) | 90.31M |
| Book Value Per Share | 1.71 |
| Working Capital | 141.78M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -95.95M |
| Capital Expenditures | -2.17M |
| Depreciation & Amortization | 1.85M |
| Net Borrowing | 19.80M |
| Free Cash Flow | -98.12M |
| FCF Per Share | -$1.86 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.87% |
| Operating Margin | -223.22% |
| Pretax Margin | -225.34% |
| Profit Margin | -225.34% |
| EBITDA Margin | -219.40% |
| EBIT Margin | -223.22% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -37.63% |
| Shareholder Yield | -37.63% |
| Earnings Yield | -25.15% |
| FCF Yield | -20.73% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.67 |
| Price Target Difference | 52.23% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 57.41% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.17 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |